Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Quoin Pharmaceuticals Ltd
QNRX
Healthcare
Biotechnology
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat...
Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:QNRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(217)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Sep 17, 2025 9:40am
Buy buddy buy.
Otherwise FOMO
(0)
•••
PressRelease
X
Post by
PressRelease
on May 22, 2025 7:30am
New Press Release - Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study
Study CL-QRX003-002 will test whole-body application of QRX003 in conjunction with off-label systemic therapy in approximately 12-15 subjects.Study CL-QRX003-002 complements first whole-body pivotal study, CL-QRX003-003, being led by Dr. Amy Paller at Northwestern University and supported by up...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 20, 2025 7:30am
New Press Release - Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome
Company continues to advance QRX003 in late-stage clinical trials in Netherton Syndrome patientsRegulatory milestone provides 10 years of market exclusivity in Europe upon approvalASHBURN, Va., May 20, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin...
read article.
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 12:34pm
QNRX....sideways action til it isn't
Volume is too low.....outside chance of a last minute "heroics" I'd say it's range bound now....$6.66 low to $7.20 high....rinse and repeat
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 11:39am
QNRX.... Dead cat bounce now??? LMFBO !
Go chit in a river.....14K / 5 min will get u no where....$7.10
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 10:43am
QNRX...I'd love to know for sure just how many Retail DT'ers
are stuck with the high priced paper trading the 1st 10 mins of the opening bell??? The hired assassins.... "The Pros" shorted the financing to all The Greater Fools willing to get lured
...more
(657)
•••
Iseneschal
X
Comment by
Iseneschal
on May 14, 2025 10:34am
RE:Using technical analysis for this stock.
R u on the "Payroll" ??????
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 10:33am
QNRX....now read my lips !
Next announcement will be a P.O news release and the share price will tank Just my 2 bits
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 10:31am
QNRX....You've all been had....AGAIN !!!!
Every freaking day ....same chit....different pile Have a great day
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 10:30am
QNRX...It's Over CFDG
$7.29.........LMFBO !!!!
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 10:22am
QNRX....the only way I would trade this is if it broke res @
$8.64
(657)
•••
Iseneschal
X
Comment by
Iseneschal
on May 14, 2025 10:20am
RE:Using technical analysis for this stock.
Always around a "Train wreck" ; )
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 10:18am
QNRX.....On the last bastion of support here at $7.99
Shall I start the drumroll now because if this doesn't rally R.F.Now....It's all over but the cryin !!!
(217)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on May 14, 2025 9:26am
Using technical analysis for this stock.
It should go up big-time and it's looking really good here for shareholders today anyway so
(657)
•••
Iseneschal
X
Post by
Iseneschal
on May 14, 2025 9:10am
QNRX....early a.m runner up on NR.... $9.25
All these trades on a thinner with this NR ; ) All this just to bury all the Chasers with high priced paper in order to raise money. P.O set up...go ahead I dare ya ! Quoin Pharmaceuticals
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Sranan Gold Reports 11 M Grading 7.33 g/t Gold Including 4 M at 14.59 g/t Gold
Global Currency Shifts Are Reshaping Commodities. Learn How. Secure Your Seat at VRIC 2026
Pinnacle Provides Progress Update for El Potrero Gold-Silver Project
Allied Critical Metals Announces Receipt of Environmental Permit for the Borralha Tungsten Project in Portugal
Sorrento Resources Announces Drilling Contract and Receives Permit to Drill Bottom Brook Project
Podcasts